Canada Biotechnology & Medical Research

Kane Biotech Inc (KNE)

Track

Track

Ticker: KNE Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kane Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
337.51
Quantity 28,161 +18.6%
Value CA$339,625
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
456.42
Quantity 35,017 +13.1%
Value CA$2,868,159
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
343.37
Quantity 6,986 -8.3%
Value CA$4,752,667
1.9
Huizinga, Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 60,000
Value CA$6,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 2,000,000 +31.3%
Value CA$200,000
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 1,000,000 +6.1%
Value CA$100,000
1.6
Dupuis, Raymond David Eugene Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.10
Quantity 100,000 +10.1%
Value CA$10,000
1.9
Huizinga, Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.13
Quantity 90,000
Value CA$11,250
1.3
Renaud, Richard J. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.10
Quantity 2,500,000 +17.1%
Value CA$250,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.14
Quantity 345,000 +5.9%
Value CA$48,300
2.0
Renaud, Philip Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.13
Quantity 2,000,000 -10.9%
Value CA$260,000
2.4
Edwards, Marc Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 125,000 +2.2%
Value CA$10,000
1.3
Renaud, Richard J. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.08
Quantity 3,125,000 +27.2%
Value CA$250,000
1.6
Dupuis, Raymond David Eugene Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.08
Quantity 125,000 +14.5%
Value CA$10,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-25 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
28,161 +18.6%
337.51
CA$339,625 		28,161 +18.6% 337.51 CA$339,625
2025-12-18 2025-12-17 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
35,017 +13.1%
456.42
CA$2,868,159 		35,017 +13.1% 456.42 CA$2,868,159
2025-05-06 2025-05-05 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
6,986 -8.3%
343.37
CA$4,752,667 		6,986 -8.3% 343.37 CA$4,752,667
2025-01-23 2025-01-17 B Purchase
1.9
Huizinga, Robert

Director of Issuer

Non-Executive Director
60,000
0.10
CA$6,000 		60,000 0.10 CA$6,000
2025-01-23 2025-01-17 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
2,000,000 +31.3%
0.10
CA$200,000 		2,000,000 +31.3% 0.10 CA$200,000
2025-01-18 2025-01-17 B Purchase
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
1,000,000 +6.1%
0.10
CA$100,000 		1,000,000 +6.1% 0.10 CA$100,000
2025-01-18 2025-01-17 B Purchase
1.6
Dupuis, Raymond David Eugene

Senior Officer of Issuer

Officer
100,000 +10.1%
0.10
CA$10,000 		100,000 +10.1% 0.10 CA$10,000
2024-09-17 2024-09-13 B Purchase
1.9
Huizinga, Robert

Director of Issuer

Non-Executive Director
90,000
0.13
CA$11,250 		90,000 0.13 CA$11,250
2024-09-12 2024-09-11 B Purchase
1.3
Renaud, Richard J.

10% Security Holder of Issuer

Large shareholder
2,500,000 +17.1%
0.10
CA$250,000 		2,500,000 +17.1% 0.10 CA$250,000
2024-06-25 2024-06-25 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
345,000 +5.9%
0.14
CA$48,300 		345,000 +5.9% 0.14 CA$48,300
2024-04-22 2024-04-17 S Sale
2.0
Renaud, Philip

Director of Issuer

Non-Executive Director
2,000,000 -10.9%
0.13
CA$260,000 		2,000,000 -10.9% 0.13 CA$260,000
2023-09-19 2023-09-11 B Purchase
2.4
Edwards, Marc

Director of Issuer

Non-Executive Director
125,000 +2.2%
0.08
CA$10,000 		125,000 +2.2% 0.08 CA$10,000
2023-09-18 2023-09-11 B Purchase
1.3
Renaud, Richard J.

10% Security Holder of Issuer

Large shareholder
3,125,000 +27.2%
0.08
CA$250,000 		3,125,000 +27.2% 0.08 CA$250,000
2023-09-13 2023-09-11 B Purchase
1.6
Dupuis, Raymond David Eugene

Senior Officer of Issuer

Officer
125,000 +14.5%
0.08
CA$10,000 		125,000 +14.5% 0.08 CA$10,000
Explore more

More insider trading research around Kane Biotech Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America